SEC Form 4 · accession 0001493152-17-007505
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Alan Berg
Director · 10% Owner
Period of report
Jun 30, 2017
Accepted (ET)
Jul 5, 2017 · 6:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 30, 2017 | A | 827 | $0.00 | A | 11,427 | D | |
| Common StockF2 | holding | — | — | — | 423,000 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This restricted stock grant was issued to the reporting person under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan and pursuant to the NTN Buzztime, Inc. Non-Employee Director Compensation Policy in lieu of a portion of the annual retainer earned by the reporting person in his capacity as a non-employee director of the issuer. This restricted stock grant was fully-vested on the date of grant.
- F2These securities are owned by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.